Global Genetically Engineered Vaccines Supply, Demand and Key Producers, 2023-2029
The global Genetically Engineered Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Genetically Engineered Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Engineered Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Engineered Vaccines total production and demand, 2018-2029, (K Units)
Global Genetically Engineered Vaccines total production value, 2018-2029, (USD Million)
Global Genetically Engineered Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Engineered Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Genetically Engineered Vaccines domestic production, consumption, key domestic manufacturers and share
Global Genetically Engineered Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Genetically Engineered Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Engineered Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Genetically Engineered Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Sanofi, Zoties and Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Engineered Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Genetically Engineered Vaccines Market, By Region:
1. How big is the global Genetically Engineered Vaccines market?
2. What is the demand of the global Genetically Engineered Vaccines market?
3. What is the year over year growth of the global Genetically Engineered Vaccines market?
4. What is the production and production value of the global Genetically Engineered Vaccines market?
5. Who are the key producers in the global Genetically Engineered Vaccines market?
6. What are the growth factors driving the market demand?
This report studies the global Genetically Engineered Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Engineered Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Engineered Vaccines total production and demand, 2018-2029, (K Units)
Global Genetically Engineered Vaccines total production value, 2018-2029, (USD Million)
Global Genetically Engineered Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Engineered Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Genetically Engineered Vaccines domestic production, consumption, key domestic manufacturers and share
Global Genetically Engineered Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Genetically Engineered Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Engineered Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Genetically Engineered Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Sanofi, Zoties and Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Engineered Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Genetically Engineered Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Veterinary Use
- Human Use
- Pfizer
- Merck
- GSK
- Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
- Walvax Biotechnology Co., Ltd.
- Bharat Biotech
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Sant? Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
1. How big is the global Genetically Engineered Vaccines market?
2. What is the demand of the global Genetically Engineered Vaccines market?
3. What is the year over year growth of the global Genetically Engineered Vaccines market?
4. What is the production and production value of the global Genetically Engineered Vaccines market?
5. Who are the key producers in the global Genetically Engineered Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genetically Engineered Vaccines Introduction
1.2 World Genetically Engineered Vaccines Supply & Forecast
1.2.1 World Genetically Engineered Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Genetically Engineered Vaccines Production (2018-2029)
1.2.3 World Genetically Engineered Vaccines Pricing Trends (2018-2029)
1.3 World Genetically Engineered Vaccines Production by Region (Based on Production Site)
1.3.1 World Genetically Engineered Vaccines Production Value by Region (2018-2029)
1.3.2 World Genetically Engineered Vaccines Production by Region (2018-2029)
1.3.3 World Genetically Engineered Vaccines Average Price by Region (2018-2029)
1.3.4 North America Genetically Engineered Vaccines Production (2018-2029)
1.3.5 Europe Genetically Engineered Vaccines Production (2018-2029)
1.3.6 China Genetically Engineered Vaccines Production (2018-2029)
1.3.7 Japan Genetically Engineered Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Engineered Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Engineered Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Genetically Engineered Vaccines Demand (2018-2029)
2.2 World Genetically Engineered Vaccines Consumption by Region
2.2.1 World Genetically Engineered Vaccines Consumption by Region (2018-2023)
2.2.2 World Genetically Engineered Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Genetically Engineered Vaccines Consumption (2018-2029)
2.4 China Genetically Engineered Vaccines Consumption (2018-2029)
2.5 Europe Genetically Engineered Vaccines Consumption (2018-2029)
2.6 Japan Genetically Engineered Vaccines Consumption (2018-2029)
2.7 South Korea Genetically Engineered Vaccines Consumption (2018-2029)
2.8 ASEAN Genetically Engineered Vaccines Consumption (2018-2029)
2.9 India Genetically Engineered Vaccines Consumption (2018-2029)
3 WORLD GENETICALLY ENGINEERED VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Engineered Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Genetically Engineered Vaccines Production by Manufacturer (2018-2023)
3.3 World Genetically Engineered Vaccines Average Price by Manufacturer (2018-2023)
3.4 Genetically Engineered Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Engineered Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Engineered Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Genetically Engineered Vaccines in 2022
3.6 Genetically Engineered Vaccines Market: Overall Company Footprint Analysis
3.6.1 Genetically Engineered Vaccines Market: Region Footprint
3.6.2 Genetically Engineered Vaccines Market: Company Product Type Footprint
3.6.3 Genetically Engineered Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Engineered Vaccines Production Value Comparison
4.1.1 United States VS China: Genetically Engineered Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Genetically Engineered Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Genetically Engineered Vaccines Production Comparison
4.2.1 United States VS China: Genetically Engineered Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Genetically Engineered Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Genetically Engineered Vaccines Consumption Comparison
4.3.1 United States VS China: Genetically Engineered Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Genetically Engineered Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Genetically Engineered Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
4.5 China Based Genetically Engineered Vaccines Manufacturers and Market Share
4.5.1 China Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
4.6 Rest of World Based Genetically Engineered Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Engineered Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genetic Recombinant Vaccine
5.2.2 Recombinant Subunit Vaccines
5.2.3 Genetic Vaccine
5.3 Market Segment by Type
5.3.1 World Genetically Engineered Vaccines Production by Type (2018-2029)
5.3.2 World Genetically Engineered Vaccines Production Value by Type (2018-2029)
5.3.3 World Genetically Engineered Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Engineered Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Veterinary Use
6.2.2 Human Use
6.3 Market Segment by Application
6.3.1 World Genetically Engineered Vaccines Production by Application (2018-2029)
6.3.2 World Genetically Engineered Vaccines Production Value by Application (2018-2029)
6.3.3 World Genetically Engineered Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Genetically Engineered Vaccines Product and Services
7.1.4 Pfizer Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Genetically Engineered Vaccines Product and Services
7.2.4 Merck Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Genetically Engineered Vaccines Product and Services
7.3.4 GSK Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Details
7.5.2 Walvax Biotechnology Co., Ltd. Major Business
7.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
7.5.4 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Walvax Biotechnology Co., Ltd. Recent Developments/Updates
7.5.6 Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Genetically Engineered Vaccines Product and Services
7.6.4 Bharat Biotech Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Genetically Engineered Vaccines Product and Services
7.7.4 Sanofi Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Zoties
7.8.1 Zoties Details
7.8.2 Zoties Major Business
7.8.3 Zoties Genetically Engineered Vaccines Product and Services
7.8.4 Zoties Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zoties Recent Developments/Updates
7.8.6 Zoties Competitive Strengths & Weaknesses
7.9 Elanco
7.9.1 Elanco Details
7.9.2 Elanco Major Business
7.9.3 Elanco Genetically Engineered Vaccines Product and Services
7.9.4 Elanco Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Elanco Recent Developments/Updates
7.9.6 Elanco Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Product and Services
7.10.4 Boehringer Ingelheim Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Details
7.11.2 Indian Immunologicals Major Business
7.11.3 Indian Immunologicals Genetically Engineered Vaccines Product and Services
7.11.4 Indian Immunologicals Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Indian Immunologicals Recent Developments/Updates
7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses
7.12 China Animal Husbandry Industry Co.,Ltd.
7.12.1 China Animal Husbandry Industry Co.,Ltd. Details
7.12.2 China Animal Husbandry Industry Co.,Ltd. Major Business
7.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product and Services
7.12.4 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
7.12.6 China Animal Husbandry Industry Co.,Ltd. Competitive Strengths & Weaknesses
7.13 Yebio Bioengineering Co., Ltd Of Qingdao
7.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Details
7.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Major Business
7.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product and Services
7.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
7.13.6 Yebio Bioengineering Co., Ltd Of Qingdao Competitive Strengths & Weaknesses
7.14 Jinyu Bio-technology Co.,ltd.
7.14.1 Jinyu Bio-technology Co.,ltd. Details
7.14.2 Jinyu Bio-technology Co.,ltd. Major Business
7.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product and Services
7.14.4 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
7.14.6 Jinyu Bio-technology Co.,ltd. Competitive Strengths & Weaknesses
7.15 HVRI
7.15.1 HVRI Details
7.15.2 HVRI Major Business
7.15.3 HVRI Genetically Engineered Vaccines Product and Services
7.15.4 HVRI Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 HVRI Recent Developments/Updates
7.15.6 HVRI Competitive Strengths & Weaknesses
7.16 Ringpu Biology
7.16.1 Ringpu Biology Details
7.16.2 Ringpu Biology Major Business
7.16.3 Ringpu Biology Genetically Engineered Vaccines Product and Services
7.16.4 Ringpu Biology Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ringpu Biology Recent Developments/Updates
7.16.6 Ringpu Biology Competitive Strengths & Weaknesses
7.17 Kyoto Biken Laboratories
7.17.1 Kyoto Biken Laboratories Details
7.17.2 Kyoto Biken Laboratories Major Business
7.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Product and Services
7.17.4 Kyoto Biken Laboratories Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Kyoto Biken Laboratories Recent Developments/Updates
7.17.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
7.18 FATRO
7.18.1 FATRO Details
7.18.2 FATRO Major Business
7.18.3 FATRO Genetically Engineered Vaccines Product and Services
7.18.4 FATRO Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 FATRO Recent Developments/Updates
7.18.6 FATRO Competitive Strengths & Weaknesses
7.19 Ceva Sant? Animale
7.19.1 Ceva Sant? Animale Details
7.19.2 Ceva Sant? Animale Major Business
7.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Product and Services
7.19.4 Ceva Sant? Animale Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Ceva Sant? Animale Recent Developments/Updates
7.19.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.20 Pulike Biological Engineering,Inc.
7.20.1 Pulike Biological Engineering,Inc. Details
7.20.2 Pulike Biological Engineering,Inc. Major Business
7.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product and Services
7.20.4 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
7.20.6 Pulike Biological Engineering,Inc. Competitive Strengths & Weaknesses
7.21 Wuhan Hvsen Biotechnology CO.,LTD
7.21.1 Wuhan Hvsen Biotechnology CO.,LTD Details
7.21.2 Wuhan Hvsen Biotechnology CO.,LTD Major Business
7.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product and Services
7.21.4 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
7.21.6 Wuhan Hvsen Biotechnology CO.,LTD Competitive Strengths & Weaknesses
7.22 Jinhe Biotechnology Co., Ltd.
7.22.1 Jinhe Biotechnology Co., Ltd. Details
7.22.2 Jinhe Biotechnology Co., Ltd. Major Business
7.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
7.22.4 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
7.22.6 Jinhe Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.23 Shanghai Shen Lian Biomedical Corporation
7.23.1 Shanghai Shen Lian Biomedical Corporation Details
7.23.2 Shanghai Shen Lian Biomedical Corporation Major Business
7.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product and Services
7.23.4 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
7.23.6 Shanghai Shen Lian Biomedical Corporation Competitive Strengths & Weaknesses
7.24 Qingdao Vland Biotech INC.
7.24.1 Qingdao Vland Biotech INC. Details
7.24.2 Qingdao Vland Biotech INC. Major Business
7.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product and Services
7.24.4 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Qingdao Vland Biotech INC. Recent Developments/Updates
7.24.6 Qingdao Vland Biotech INC. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Engineered Vaccines Industry Chain
8.2 Genetically Engineered Vaccines Upstream Analysis
8.2.1 Genetically Engineered Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Genetically Engineered Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Engineered Vaccines Production Mode
8.6 Genetically Engineered Vaccines Procurement Model
8.7 Genetically Engineered Vaccines Industry Sales Model and Sales Channels
8.7.1 Genetically Engineered Vaccines Sales Model
8.7.2 Genetically Engineered Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Genetically Engineered Vaccines Introduction
1.2 World Genetically Engineered Vaccines Supply & Forecast
1.2.1 World Genetically Engineered Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Genetically Engineered Vaccines Production (2018-2029)
1.2.3 World Genetically Engineered Vaccines Pricing Trends (2018-2029)
1.3 World Genetically Engineered Vaccines Production by Region (Based on Production Site)
1.3.1 World Genetically Engineered Vaccines Production Value by Region (2018-2029)
1.3.2 World Genetically Engineered Vaccines Production by Region (2018-2029)
1.3.3 World Genetically Engineered Vaccines Average Price by Region (2018-2029)
1.3.4 North America Genetically Engineered Vaccines Production (2018-2029)
1.3.5 Europe Genetically Engineered Vaccines Production (2018-2029)
1.3.6 China Genetically Engineered Vaccines Production (2018-2029)
1.3.7 Japan Genetically Engineered Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Engineered Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Engineered Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Genetically Engineered Vaccines Demand (2018-2029)
2.2 World Genetically Engineered Vaccines Consumption by Region
2.2.1 World Genetically Engineered Vaccines Consumption by Region (2018-2023)
2.2.2 World Genetically Engineered Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Genetically Engineered Vaccines Consumption (2018-2029)
2.4 China Genetically Engineered Vaccines Consumption (2018-2029)
2.5 Europe Genetically Engineered Vaccines Consumption (2018-2029)
2.6 Japan Genetically Engineered Vaccines Consumption (2018-2029)
2.7 South Korea Genetically Engineered Vaccines Consumption (2018-2029)
2.8 ASEAN Genetically Engineered Vaccines Consumption (2018-2029)
2.9 India Genetically Engineered Vaccines Consumption (2018-2029)
3 WORLD GENETICALLY ENGINEERED VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Engineered Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Genetically Engineered Vaccines Production by Manufacturer (2018-2023)
3.3 World Genetically Engineered Vaccines Average Price by Manufacturer (2018-2023)
3.4 Genetically Engineered Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Engineered Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Engineered Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Genetically Engineered Vaccines in 2022
3.6 Genetically Engineered Vaccines Market: Overall Company Footprint Analysis
3.6.1 Genetically Engineered Vaccines Market: Region Footprint
3.6.2 Genetically Engineered Vaccines Market: Company Product Type Footprint
3.6.3 Genetically Engineered Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Engineered Vaccines Production Value Comparison
4.1.1 United States VS China: Genetically Engineered Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Genetically Engineered Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Genetically Engineered Vaccines Production Comparison
4.2.1 United States VS China: Genetically Engineered Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Genetically Engineered Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Genetically Engineered Vaccines Consumption Comparison
4.3.1 United States VS China: Genetically Engineered Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Genetically Engineered Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Genetically Engineered Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
4.5 China Based Genetically Engineered Vaccines Manufacturers and Market Share
4.5.1 China Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
4.6 Rest of World Based Genetically Engineered Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Genetically Engineered Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Engineered Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genetic Recombinant Vaccine
5.2.2 Recombinant Subunit Vaccines
5.2.3 Genetic Vaccine
5.3 Market Segment by Type
5.3.1 World Genetically Engineered Vaccines Production by Type (2018-2029)
5.3.2 World Genetically Engineered Vaccines Production Value by Type (2018-2029)
5.3.3 World Genetically Engineered Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Engineered Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Veterinary Use
6.2.2 Human Use
6.3 Market Segment by Application
6.3.1 World Genetically Engineered Vaccines Production by Application (2018-2029)
6.3.2 World Genetically Engineered Vaccines Production Value by Application (2018-2029)
6.3.3 World Genetically Engineered Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Genetically Engineered Vaccines Product and Services
7.1.4 Pfizer Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Genetically Engineered Vaccines Product and Services
7.2.4 Merck Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Genetically Engineered Vaccines Product and Services
7.3.4 GSK Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Details
7.5.2 Walvax Biotechnology Co., Ltd. Major Business
7.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
7.5.4 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Walvax Biotechnology Co., Ltd. Recent Developments/Updates
7.5.6 Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Genetically Engineered Vaccines Product and Services
7.6.4 Bharat Biotech Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Genetically Engineered Vaccines Product and Services
7.7.4 Sanofi Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Zoties
7.8.1 Zoties Details
7.8.2 Zoties Major Business
7.8.3 Zoties Genetically Engineered Vaccines Product and Services
7.8.4 Zoties Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zoties Recent Developments/Updates
7.8.6 Zoties Competitive Strengths & Weaknesses
7.9 Elanco
7.9.1 Elanco Details
7.9.2 Elanco Major Business
7.9.3 Elanco Genetically Engineered Vaccines Product and Services
7.9.4 Elanco Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Elanco Recent Developments/Updates
7.9.6 Elanco Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Product and Services
7.10.4 Boehringer Ingelheim Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Details
7.11.2 Indian Immunologicals Major Business
7.11.3 Indian Immunologicals Genetically Engineered Vaccines Product and Services
7.11.4 Indian Immunologicals Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Indian Immunologicals Recent Developments/Updates
7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses
7.12 China Animal Husbandry Industry Co.,Ltd.
7.12.1 China Animal Husbandry Industry Co.,Ltd. Details
7.12.2 China Animal Husbandry Industry Co.,Ltd. Major Business
7.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product and Services
7.12.4 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
7.12.6 China Animal Husbandry Industry Co.,Ltd. Competitive Strengths & Weaknesses
7.13 Yebio Bioengineering Co., Ltd Of Qingdao
7.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Details
7.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Major Business
7.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product and Services
7.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
7.13.6 Yebio Bioengineering Co., Ltd Of Qingdao Competitive Strengths & Weaknesses
7.14 Jinyu Bio-technology Co.,ltd.
7.14.1 Jinyu Bio-technology Co.,ltd. Details
7.14.2 Jinyu Bio-technology Co.,ltd. Major Business
7.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product and Services
7.14.4 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
7.14.6 Jinyu Bio-technology Co.,ltd. Competitive Strengths & Weaknesses
7.15 HVRI
7.15.1 HVRI Details
7.15.2 HVRI Major Business
7.15.3 HVRI Genetically Engineered Vaccines Product and Services
7.15.4 HVRI Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 HVRI Recent Developments/Updates
7.15.6 HVRI Competitive Strengths & Weaknesses
7.16 Ringpu Biology
7.16.1 Ringpu Biology Details
7.16.2 Ringpu Biology Major Business
7.16.3 Ringpu Biology Genetically Engineered Vaccines Product and Services
7.16.4 Ringpu Biology Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ringpu Biology Recent Developments/Updates
7.16.6 Ringpu Biology Competitive Strengths & Weaknesses
7.17 Kyoto Biken Laboratories
7.17.1 Kyoto Biken Laboratories Details
7.17.2 Kyoto Biken Laboratories Major Business
7.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Product and Services
7.17.4 Kyoto Biken Laboratories Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Kyoto Biken Laboratories Recent Developments/Updates
7.17.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
7.18 FATRO
7.18.1 FATRO Details
7.18.2 FATRO Major Business
7.18.3 FATRO Genetically Engineered Vaccines Product and Services
7.18.4 FATRO Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 FATRO Recent Developments/Updates
7.18.6 FATRO Competitive Strengths & Weaknesses
7.19 Ceva Sant? Animale
7.19.1 Ceva Sant? Animale Details
7.19.2 Ceva Sant? Animale Major Business
7.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Product and Services
7.19.4 Ceva Sant? Animale Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Ceva Sant? Animale Recent Developments/Updates
7.19.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.20 Pulike Biological Engineering,Inc.
7.20.1 Pulike Biological Engineering,Inc. Details
7.20.2 Pulike Biological Engineering,Inc. Major Business
7.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product and Services
7.20.4 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
7.20.6 Pulike Biological Engineering,Inc. Competitive Strengths & Weaknesses
7.21 Wuhan Hvsen Biotechnology CO.,LTD
7.21.1 Wuhan Hvsen Biotechnology CO.,LTD Details
7.21.2 Wuhan Hvsen Biotechnology CO.,LTD Major Business
7.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product and Services
7.21.4 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
7.21.6 Wuhan Hvsen Biotechnology CO.,LTD Competitive Strengths & Weaknesses
7.22 Jinhe Biotechnology Co., Ltd.
7.22.1 Jinhe Biotechnology Co., Ltd. Details
7.22.2 Jinhe Biotechnology Co., Ltd. Major Business
7.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
7.22.4 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
7.22.6 Jinhe Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.23 Shanghai Shen Lian Biomedical Corporation
7.23.1 Shanghai Shen Lian Biomedical Corporation Details
7.23.2 Shanghai Shen Lian Biomedical Corporation Major Business
7.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product and Services
7.23.4 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
7.23.6 Shanghai Shen Lian Biomedical Corporation Competitive Strengths & Weaknesses
7.24 Qingdao Vland Biotech INC.
7.24.1 Qingdao Vland Biotech INC. Details
7.24.2 Qingdao Vland Biotech INC. Major Business
7.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product and Services
7.24.4 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Qingdao Vland Biotech INC. Recent Developments/Updates
7.24.6 Qingdao Vland Biotech INC. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Engineered Vaccines Industry Chain
8.2 Genetically Engineered Vaccines Upstream Analysis
8.2.1 Genetically Engineered Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Genetically Engineered Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Engineered Vaccines Production Mode
8.6 Genetically Engineered Vaccines Procurement Model
8.7 Genetically Engineered Vaccines Industry Sales Model and Sales Channels
8.7.1 Genetically Engineered Vaccines Sales Model
8.7.2 Genetically Engineered Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Genetically Engineered Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Genetically Engineered Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Genetically Engineered Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Genetically Engineered Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Genetically Engineered Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Genetically Engineered Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Genetically Engineered Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Genetically Engineered Vaccines Production Market Share by Region (2018-2023)
Table 9. World Genetically Engineered Vaccines Production Market Share by Region (2024-2029)
Table 10. World Genetically Engineered Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Genetically Engineered Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Genetically Engineered Vaccines Major Market Trends
Table 13. World Genetically Engineered Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Genetically Engineered Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Genetically Engineered Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Genetically Engineered Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Engineered Vaccines Producers in 2022
Table 18. World Genetically Engineered Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Genetically Engineered Vaccines Producers in 2022
Table 20. World Genetically Engineered Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Genetically Engineered Vaccines Company Evaluation Quadrant
Table 22. World Genetically Engineered Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Genetically Engineered Vaccines Production Site of Key Manufacturer
Table 24. Genetically Engineered Vaccines Market: Company Product Type Footprint
Table 25. Genetically Engineered Vaccines Market: Company Product Application Footprint
Table 26. Genetically Engineered Vaccines Competitive Factors
Table 27. Genetically Engineered Vaccines New Entrant and Capacity Expansion Plans
Table 28. Genetically Engineered Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Engineered Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Genetically Engineered Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Genetically Engineered Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 37. China Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 47. World Genetically Engineered Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Genetically Engineered Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Genetically Engineered Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Genetically Engineered Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Genetically Engineered Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Genetically Engineered Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Genetically Engineered Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Genetically Engineered Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Genetically Engineered Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Genetically Engineered Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Genetically Engineered Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Genetically Engineered Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Genetically Engineered Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Genetically Engineered Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Genetically Engineered Vaccines Product and Services
Table 64. Pfizer Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Genetically Engineered Vaccines Product and Services
Table 70. Merck Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Genetically Engineered Vaccines Product and Services
Table 76. GSK Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Co., Ltd. Major Business
Table 87. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
Table 88. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Genetically Engineered Vaccines Product and Services
Table 94. Bharat Biotech Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Genetically Engineered Vaccines Product and Services
Table 100. Sanofi Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Zoties Basic Information, Manufacturing Base and Competitors
Table 104. Zoties Major Business
Table 105. Zoties Genetically Engineered Vaccines Product and Services
Table 106. Zoties Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Zoties Recent Developments/Updates
Table 108. Zoties Competitive Strengths & Weaknesses
Table 109. Elanco Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Major Business
Table 111. Elanco Genetically Engineered Vaccines Product and Services
Table 112. Elanco Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Elanco Recent Developments/Updates
Table 114. Elanco Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Genetically Engineered Vaccines Product and Services
Table 118. Boehringer Ingelheim Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 122. Indian Immunologicals Major Business
Table 123. Indian Immunologicals Genetically Engineered Vaccines Product and Services
Table 124. Indian Immunologicals Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Indian Immunologicals Recent Developments/Updates
Table 126. Indian Immunologicals Competitive Strengths & Weaknesses
Table 127. China Animal Husbandry Industry Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. China Animal Husbandry Industry Co.,Ltd. Major Business
Table 129. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product and Services
Table 130. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 132. China Animal Husbandry Industry Co.,Ltd. Competitive Strengths & Weaknesses
Table 133. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Manufacturing Base and Competitors
Table 134. Yebio Bioengineering Co., Ltd Of Qingdao Major Business
Table 135. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product and Services
Table 136. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 138. Yebio Bioengineering Co., Ltd Of Qingdao Competitive Strengths & Weaknesses
Table 139. Jinyu Bio-technology Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Jinyu Bio-technology Co.,ltd. Major Business
Table 141. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product and Services
Table 142. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 144. Jinyu Bio-technology Co.,ltd. Competitive Strengths & Weaknesses
Table 145. HVRI Basic Information, Manufacturing Base and Competitors
Table 146. HVRI Major Business
Table 147. HVRI Genetically Engineered Vaccines Product and Services
Table 148. HVRI Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. HVRI Recent Developments/Updates
Table 150. HVRI Competitive Strengths & Weaknesses
Table 151. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 152. Ringpu Biology Major Business
Table 153. Ringpu Biology Genetically Engineered Vaccines Product and Services
Table 154. Ringpu Biology Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ringpu Biology Recent Developments/Updates
Table 156. Ringpu Biology Competitive Strengths & Weaknesses
Table 157. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 158. Kyoto Biken Laboratories Major Business
Table 159. Kyoto Biken Laboratories Genetically Engineered Vaccines Product and Services
Table 160. Kyoto Biken Laboratories Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Kyoto Biken Laboratories Recent Developments/Updates
Table 162. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 163. FATRO Basic Information, Manufacturing Base and Competitors
Table 164. FATRO Major Business
Table 165. FATRO Genetically Engineered Vaccines Product and Services
Table 166. FATRO Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. FATRO Recent Developments/Updates
Table 168. FATRO Competitive Strengths & Weaknesses
Table 169. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 170. Ceva Sant? Animale Major Business
Table 171. Ceva Sant? Animale Genetically Engineered Vaccines Product and Services
Table 172. Ceva Sant? Animale Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Ceva Sant? Animale Recent Developments/Updates
Table 174. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 175. Pulike Biological Engineering,Inc. Basic Information, Manufacturing Base and Competitors
Table 176. Pulike Biological Engineering,Inc. Major Business
Table 177. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product and Services
Table 178. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 180. Pulike Biological Engineering,Inc. Competitive Strengths & Weaknesses
Table 181. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 182. Wuhan Hvsen Biotechnology CO.,LTD Major Business
Table 183. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product and Services
Table 184. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 186. Wuhan Hvsen Biotechnology CO.,LTD Competitive Strengths & Weaknesses
Table 187. Jinhe Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 188. Jinhe Biotechnology Co., Ltd. Major Business
Table 189. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
Table 190. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 192. Jinhe Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 193. Shanghai Shen Lian Biomedical Corporation Basic Information, Manufacturing Base and Competitors
Table 194. Shanghai Shen Lian Biomedical Corporation Major Business
Table 195. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product and Services
Table 196. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 198. Qingdao Vland Biotech INC. Basic Information, Manufacturing Base and Competitors
Table 199. Qingdao Vland Biotech INC. Major Business
Table 200. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product and Services
Table 201. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 202. Global Key Players of Genetically Engineered Vaccines Upstream (Raw Materials)
Table 203. Genetically Engineered Vaccines Typical Customers
Table 204. Genetically Engineered Vaccines Typical Distributors
Table 1. World Genetically Engineered Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Genetically Engineered Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Genetically Engineered Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Genetically Engineered Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Genetically Engineered Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Genetically Engineered Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Genetically Engineered Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Genetically Engineered Vaccines Production Market Share by Region (2018-2023)
Table 9. World Genetically Engineered Vaccines Production Market Share by Region (2024-2029)
Table 10. World Genetically Engineered Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Genetically Engineered Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Genetically Engineered Vaccines Major Market Trends
Table 13. World Genetically Engineered Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Genetically Engineered Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Genetically Engineered Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Genetically Engineered Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Engineered Vaccines Producers in 2022
Table 18. World Genetically Engineered Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Genetically Engineered Vaccines Producers in 2022
Table 20. World Genetically Engineered Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Genetically Engineered Vaccines Company Evaluation Quadrant
Table 22. World Genetically Engineered Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Genetically Engineered Vaccines Production Site of Key Manufacturer
Table 24. Genetically Engineered Vaccines Market: Company Product Type Footprint
Table 25. Genetically Engineered Vaccines Market: Company Product Application Footprint
Table 26. Genetically Engineered Vaccines Competitive Factors
Table 27. Genetically Engineered Vaccines New Entrant and Capacity Expansion Plans
Table 28. Genetically Engineered Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Engineered Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Genetically Engineered Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Genetically Engineered Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 37. China Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Genetically Engineered Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Genetically Engineered Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Market Share (2018-2023)
Table 47. World Genetically Engineered Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Genetically Engineered Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Genetically Engineered Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Genetically Engineered Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Genetically Engineered Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Genetically Engineered Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Genetically Engineered Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Genetically Engineered Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Genetically Engineered Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Genetically Engineered Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Genetically Engineered Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Genetically Engineered Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Genetically Engineered Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Genetically Engineered Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Genetically Engineered Vaccines Product and Services
Table 64. Pfizer Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Genetically Engineered Vaccines Product and Services
Table 70. Merck Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Genetically Engineered Vaccines Product and Services
Table 76. GSK Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Co., Ltd. Major Business
Table 87. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
Table 88. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Genetically Engineered Vaccines Product and Services
Table 94. Bharat Biotech Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Genetically Engineered Vaccines Product and Services
Table 100. Sanofi Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Zoties Basic Information, Manufacturing Base and Competitors
Table 104. Zoties Major Business
Table 105. Zoties Genetically Engineered Vaccines Product and Services
Table 106. Zoties Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Zoties Recent Developments/Updates
Table 108. Zoties Competitive Strengths & Weaknesses
Table 109. Elanco Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Major Business
Table 111. Elanco Genetically Engineered Vaccines Product and Services
Table 112. Elanco Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Elanco Recent Developments/Updates
Table 114. Elanco Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Genetically Engineered Vaccines Product and Services
Table 118. Boehringer Ingelheim Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 122. Indian Immunologicals Major Business
Table 123. Indian Immunologicals Genetically Engineered Vaccines Product and Services
Table 124. Indian Immunologicals Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Indian Immunologicals Recent Developments/Updates
Table 126. Indian Immunologicals Competitive Strengths & Weaknesses
Table 127. China Animal Husbandry Industry Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. China Animal Husbandry Industry Co.,Ltd. Major Business
Table 129. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product and Services
Table 130. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 132. China Animal Husbandry Industry Co.,Ltd. Competitive Strengths & Weaknesses
Table 133. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Manufacturing Base and Competitors
Table 134. Yebio Bioengineering Co., Ltd Of Qingdao Major Business
Table 135. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product and Services
Table 136. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 138. Yebio Bioengineering Co., Ltd Of Qingdao Competitive Strengths & Weaknesses
Table 139. Jinyu Bio-technology Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Jinyu Bio-technology Co.,ltd. Major Business
Table 141. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product and Services
Table 142. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 144. Jinyu Bio-technology Co.,ltd. Competitive Strengths & Weaknesses
Table 145. HVRI Basic Information, Manufacturing Base and Competitors
Table 146. HVRI Major Business
Table 147. HVRI Genetically Engineered Vaccines Product and Services
Table 148. HVRI Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. HVRI Recent Developments/Updates
Table 150. HVRI Competitive Strengths & Weaknesses
Table 151. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 152. Ringpu Biology Major Business
Table 153. Ringpu Biology Genetically Engineered Vaccines Product and Services
Table 154. Ringpu Biology Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ringpu Biology Recent Developments/Updates
Table 156. Ringpu Biology Competitive Strengths & Weaknesses
Table 157. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 158. Kyoto Biken Laboratories Major Business
Table 159. Kyoto Biken Laboratories Genetically Engineered Vaccines Product and Services
Table 160. Kyoto Biken Laboratories Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Kyoto Biken Laboratories Recent Developments/Updates
Table 162. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 163. FATRO Basic Information, Manufacturing Base and Competitors
Table 164. FATRO Major Business
Table 165. FATRO Genetically Engineered Vaccines Product and Services
Table 166. FATRO Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. FATRO Recent Developments/Updates
Table 168. FATRO Competitive Strengths & Weaknesses
Table 169. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 170. Ceva Sant? Animale Major Business
Table 171. Ceva Sant? Animale Genetically Engineered Vaccines Product and Services
Table 172. Ceva Sant? Animale Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Ceva Sant? Animale Recent Developments/Updates
Table 174. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 175. Pulike Biological Engineering,Inc. Basic Information, Manufacturing Base and Competitors
Table 176. Pulike Biological Engineering,Inc. Major Business
Table 177. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product and Services
Table 178. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 180. Pulike Biological Engineering,Inc. Competitive Strengths & Weaknesses
Table 181. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 182. Wuhan Hvsen Biotechnology CO.,LTD Major Business
Table 183. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product and Services
Table 184. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 186. Wuhan Hvsen Biotechnology CO.,LTD Competitive Strengths & Weaknesses
Table 187. Jinhe Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 188. Jinhe Biotechnology Co., Ltd. Major Business
Table 189. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product and Services
Table 190. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 192. Jinhe Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 193. Shanghai Shen Lian Biomedical Corporation Basic Information, Manufacturing Base and Competitors
Table 194. Shanghai Shen Lian Biomedical Corporation Major Business
Table 195. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product and Services
Table 196. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 198. Qingdao Vland Biotech INC. Basic Information, Manufacturing Base and Competitors
Table 199. Qingdao Vland Biotech INC. Major Business
Table 200. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product and Services
Table 201. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 202. Global Key Players of Genetically Engineered Vaccines Upstream (Raw Materials)
Table 203. Genetically Engineered Vaccines Typical Customers
Table 204. Genetically Engineered Vaccines Typical Distributors
LIST OF FIGURES
Figure 1. Genetically Engineered Vaccines Picture
Figure 2. World Genetically Engineered Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Genetically Engineered Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 5. World Genetically Engineered Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Genetically Engineered Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Genetically Engineered Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 10. China Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 12. Genetically Engineered Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Genetically Engineered Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Genetically Engineered Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Engineered Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Engineered Vaccines Markets in 2022
Figure 26. United States VS China: Genetically Engineered Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Genetically Engineered Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Genetically Engineered Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 32. World Genetically Engineered Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Genetically Engineered Vaccines Production Value Market Share by Type in 2022
Figure 34. Genetic Recombinant Vaccine
Figure 35. Recombinant Subunit Vaccines
Figure 36. Genetic Vaccine
Figure 37. World Genetically Engineered Vaccines Production Market Share by Type (2018-2029)
Figure 38. World Genetically Engineered Vaccines Production Value Market Share by Type (2018-2029)
Figure 39. World Genetically Engineered Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Genetically Engineered Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Genetically Engineered Vaccines Production Value Market Share by Application in 2022
Figure 42. Veterinary Use
Figure 43. Human Use
Figure 44. World Genetically Engineered Vaccines Production Market Share by Application (2018-2029)
Figure 45. World Genetically Engineered Vaccines Production Value Market Share by Application (2018-2029)
Figure 46. World Genetically Engineered Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Genetically Engineered Vaccines Industry Chain
Figure 48. Genetically Engineered Vaccines Procurement Model
Figure 49. Genetically Engineered Vaccines Sales Model
Figure 50. Genetically Engineered Vaccines Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Genetically Engineered Vaccines Picture
Figure 2. World Genetically Engineered Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Genetically Engineered Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 5. World Genetically Engineered Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Genetically Engineered Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Genetically Engineered Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 10. China Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Genetically Engineered Vaccines Production (2018-2029) & (K Units)
Figure 12. Genetically Engineered Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Genetically Engineered Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Genetically Engineered Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Genetically Engineered Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Engineered Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Engineered Vaccines Markets in 2022
Figure 26. United States VS China: Genetically Engineered Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Genetically Engineered Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Genetically Engineered Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Genetically Engineered Vaccines Production Market Share 2022
Figure 32. World Genetically Engineered Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Genetically Engineered Vaccines Production Value Market Share by Type in 2022
Figure 34. Genetic Recombinant Vaccine
Figure 35. Recombinant Subunit Vaccines
Figure 36. Genetic Vaccine
Figure 37. World Genetically Engineered Vaccines Production Market Share by Type (2018-2029)
Figure 38. World Genetically Engineered Vaccines Production Value Market Share by Type (2018-2029)
Figure 39. World Genetically Engineered Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Genetically Engineered Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Genetically Engineered Vaccines Production Value Market Share by Application in 2022
Figure 42. Veterinary Use
Figure 43. Human Use
Figure 44. World Genetically Engineered Vaccines Production Market Share by Application (2018-2029)
Figure 45. World Genetically Engineered Vaccines Production Value Market Share by Application (2018-2029)
Figure 46. World Genetically Engineered Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Genetically Engineered Vaccines Industry Chain
Figure 48. Genetically Engineered Vaccines Procurement Model
Figure 49. Genetically Engineered Vaccines Sales Model
Figure 50. Genetically Engineered Vaccines Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
